ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

India lifts export ban of potential coronavirus drug after Trump threat

New Delhi to supply hydroxychloroquine to nations badly hit

NEW DELHI -- India on Tuesday announced it would allow a limited export of an anti-malaria drug seen as helpful in the treatment of the new coronavirus, a day after U.S. President Donald Trump warned of retaliation if New Delhi did not heed his request to supply the medicine to his country.

The South Asian country -- which is the largest producer of hydroxychloroquine, or HCQ, a drug touted by Trump as a "game-changer" in the fight against the coronavirus pandemic -- had on Apr. 4 said the export of the drug and formulations made from it would "remain prohibited, without any exception," as its own COVID-19 cases were beginning to spike.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more